Notch1 Can Contribute to Viral-Induced Transformation of Primary Human Keratinocytes

Cancer Research

Volumn 63, Issue 24, 2003, Pages 8687-8694

  Lathion, Stéphanie ^a   Schaper, Janina ^a   Beard, Peter ^a   Raj, Kenneth ^a  

^a SWISS INST FOR EXP CANCER RESEARCH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; NOTCH1 RECEPTOR; ONCOGENE PROTEIN E6, HUMAN PAPILLOMAVIRUS TYPE 16; ONCOGENE PROTEIN E7 HUMAN PAPILLOMAVIRUS TYPE 16; ONCOGENE PROTEIN E7-HUMAN PAPILLOMAVIRUS TYPE 16; ONCOPROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN E6; PROTEIN E7; TAN 1 PROTEIN; TAN-1 PROTEIN;

ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOSYNTHESIS; CANCER CELL CULTURE; CANCER GRADING; CELL DIVISION; CELL IMMORTALIZATION; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; GENE REPRESSION; GENETIC TRANSFECTION; GENETICS; HELA CELL; HUMAN; HUMAN CELL; KERATINOCYTE; METABOLISM; MOUSE; MUTATION; NONHUMAN; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UTERINE CERVIX CANCER; UTERINE CERVIX TUMOR; VIROLOGY; VIRUS CELL TRANSFORMATION; WART VIRUS;

ANIMALS; CELL DIVISION; CELL TRANSFORMATION, VIRAL; FEMALE; HELA CELLS; HUMANS; KERATINOCYTES; MICE; MICE, NUDE; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PROMOTER REGIONS (GENETICS); RECEPTOR, NOTCH1; RECEPTORS, CELL SURFACE; REPRESSOR PROTEINS; TRANSCRIPTION FACTORS; TRANSFECTION; UTERINE CERVICAL NEOPLASMS;

EID: 0347320748     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Cullen, A. P., Reid, R., Campion, M., and Lorincz, A. T. Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm. J. Virol., 65: 606-612, 1991.
2. Walboomers, J. M., Jacobs, M. V., Manos, M. M., Bosch, F. X., Kummer, J. A., Shah, K. V., Snijders, P. J., Peto, J., Meijer, C. J., and Munoz, N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol., 189: 12-19, 1999.
3. Munger, K., Basile, J. R., Duensing, S., Eichten, A., Gonzalez, S. L., Grace, M., and Zacny, V. L. Biological activities and molecular targets of the human papillomavirus E7 oncoprotein. Oncogene, 20: 7888-7898, 2001.
4. Klingelhutz, A. J., Foster, S. A., and McDougall, J. K. Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature (Lond.), 380: 79-82, 1996.
5. Mantovani, F., and Banks, L. The human papillomavirus E6 protein and its contribution to malignant progression. Oncogene, 20: 7874-7887, 2001.
6. Scheffner, M., Wemess, B. A., Huibregtse, J. M., Levine, A. J., and Howley, P. M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell, 63: 1129-1136, 1990.
7. Daniel, B., Rangarajan, A., Mukherjee, G., Vallikad, E., and Krishna, S. The link between integration and expression of human papillomavirus type 16 genomes and cellular changes in the evolution of cervical intraepithelial neoplastic lesions. J. Gen. Virol., 78: 1095-1101, 1997.
8. Zagouras, P., Stifani, S., Blaumueller, C. M., Carcangiu, M. L., and Artavanis-Tsakonas, S. Alterations in Notch signaling in neoplastic lesions of the human cervix. Proc. Natl. Acad. Sci. USA, 92: 6414-6418, 1995.
9. Allenspach, E. J., Maillard, I., Aster, J. C., and Pear, W. S. Notch signaling in cancer. Cancer Biol. Ther., 1: 466-476, 2002.
10. Rangarajan, A., Syal, R., Selvarajah, S., Chakrabarti, O., Sarin, A., and Krishna, S. Activated Notch1 signaling cooperates with papillomavirus oncogenes in transformation and generates resistance to apoptosis on matrix withdrawal through PKB/Akt. Virology, 286: 23-30, 2001.
11. Weijzen, S., Rizzo, P., Braid, M., Vaishnav, R., Jonkheer, S. M., Zlobin, A., Osborne, B. A., Gottipati, S., Aster, J. C., Hahn, W. C., Rudolf, M., Siziopikou, K., Kast, W. M., and Miele, L. Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells, Nat. Med., 8: 979-986, 2002.
12. Weijzen, S., Zlobin, A., Braid, M., Miele, L., and Kast, W. M. HPV16 E6 and E7 oncoproteins regulate Notch-1 expression and cooperate to induce transformation. J. Cell Physiol., 194: 356-362, 2003.
13. Talora, C., Sgroi, D. C., Crum, C. P., and Dotto, G. P. Specific down-modulation of Notch1 signaling in cervical cancer cells is required for sustained HPV-E6/E7 expression and late steps of malignant transformation. Genes Dev., 16: 2252-2263, 2002.
14. Rangarajan, A., Talora, C., Okuyama, R., Nicolas, M., Mammucari, C., Oh, H., Aster, J. C., Krishna, S., Metzger, D., Chambon, P., Miele, L., Aguet, M., Radtke, F., and Dotto, G. P. Notch signaling is a direct determinant of keratinocyte growth arrest and entry into differentiation. EMBO J., 20: 3427-3436, 2001.
15. Nicolas, M., Wolfer, A., Raj, K., Kummer, J. A., Mill, P., Van Noort, M., Hui, C. C., Clevers, H., Dotto, G. P., and Radtke, F. Notch1 functions as a tumor suppressor in mouse skin. Nat. Genet., 33: 416-421, 2003.
16. Leethanakul, C., Patel, V., Gillespie, J., Pallente, M., Ensley, J. F., Koontongkaew, S., Liotta, L. A., Emmert-Buck, M., and Gutkind, J. S. Distinct pattern of expression of differentiation and growth-related genes in squamous cell carcinomas of the head and neck revealed by the use of laser capture microdissection and cDNA arrays. Oncogene, 19: 3220-3224, 2000.
17. Suzuki, T., Aoki, D., Susumu, N., Udagawa, Y., and Nozawa, S. Imbalanced expression of TAN-1 and human Notch4 in endometrial cancers. Int. J. Oncol., 17: 1131-1139, 2000.
18. Ellisen, L. W., Bird, J., West, D. C., Soreng, A. L., Reynolds, T. C., Smith, S. D., and Sklar, J. TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell, 66: 649-661, 1991.
19. Jundt, F., Anagnostopoulos, I., Forster, R., Mathas, S., Stein, H., and Dorken, B. Activated Notch1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma. Blood, 99: 3398-3403, 2002.
20. Stanley, M. A., Browne, H. M., Appleby, M., and Minson, A. C. Properties of a non-tumorigenic human cervical keratinocyte cell line, Int. J. Cancer, 43: 672-676, 1989.
21. Bechtold, V., Beard, P., and Raj, K. Human papillomavirus type 16 E2 protein has no effect on transcription from episomal viral DNA. J. Virol., 77: 2021-2028, 2003.
22. Butz, K., and Hoppe-Seyler, F. Transcriptional control of human papillomavirus (HPV) oncogene expression: composition of the HPV type 18 upstream regulatory region. J. Virol., 67: 6476-6486, 1993.
23. Bauknecht, T., See, R. H., and Shi, Y. A novel C/EBP β-YY1 complex controls the cell-type-specific activity of the human papillomavirus type 18 upstream regulatory region. J. Virol., 70: 7695-7705, 1996.
24. Rodriguez-Viciana, P., Warne, P. H., Vanhaesebroeck, B., Waterfield, M. D., and Downward, J. Activation of phosphoinositide 3-kinase by interaction with Ras and by point mutation. EMBO J., 15: 2442-2451, 1996.
25. Ma, Y. Y., Wei, S. J., Lin, Y. C., Lung, J. C., Chang, T. C., Whang-Peng, J., Liu, J. M., Yang, D. M., Yang, W. K., and Shen, C. Y. P1K3CA as an oncogene in cervical cancer. Oncogene, 19: 2739-2744, 2000.
26. Heselmeyer, K., Schrock, E., du Manoir, S., Blegen, H., Shah, K., Steinbeck, R., Auer, G., and Ried, T. Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix. Proc. Natl. Acad. Sci. USA, 93: 479-484, 1996.
27. Rooney, P. H., Murray, G. I., Stevenson, D. A., Haites, N. E., Cassidy, J., and McLeod, H. L. Comparative genomic hybridization and chromosomal instability in solid tumours. Br. J. Cancer, 80: 862-873, 1999.
28. Jeon, S., Allen-Hoffmann, B. L., and Lambert, P. F. Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells. J. Virol., 69: 2989-2997, 1995.
29. Offord, E. A., and Beard, P. A member of the activator protein 1 family found in keratinocytes but not in fibroblasts required for transcription from a human papillomavirus type 18 promoter. J. Virol., 64: 4792-4798, 1990.
30. Offord, E. A., Chappuis, P. O., and Beard, P. Different stability of AP1 proteins in human keratinocyte and fibroblast cells: possible role in the cell-type specific expression of human papillomavirus type 18 genes. Carcinogenesis (Lond.), 14: 2447-2455, 1993.
31. Stock, R. P., and Bialy, H. The sigmoidal curve of cancer. Nat. Biotechnol., 21: 13-14, 2003.
32. Zhang, L., Zhou, W., Velculescu, V. E., Kem, S. E., Hruban, R. H., Hamilton, S. R., Vogelstein, B., and Kinzler, K. W. Gene expression profiles in normal and cancer cells. Science (Wash. DC), 276: 1268-1272, 1997.
33. Bos, J. L. The ras gene family and human carcinogenesis, Mutat. Res., 195: 255-271, 1988.
34. Field, J. K., and Spandidos, D. A. The role of ras and myc oncogenes in human solid tumours and their relevance in diagnosis and prognosis (review). Anticancer Res., 10: 1-22, 1990.
35. Land, H., Parada, L. F., and Weinberg, R. A. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature (Lond.), 304: 596-602, 1983.
36. Evan, G. I., Wyllie, A. H., Gilbert, C. S., Littlewood, T. D., Land, H., Brooks, M., Waters, C. M., Penn, L. Z., and Hancock, D. C. Induction of apoptosis in fibroblasts by c-myc protein. Cell, 69: 119-128, 1992.
37. Newbold, R. F., and Overell, R. W. Fibroblast immortality is a prerequisite for transformation by EJ c-Ha-ras oncogene. Nature (Lond.), 304: 648-651, 1983.
38. Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., and Lowe, S. W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell, 88: 593-602, 1997.
39. Dyson, N., Howley, P. M., Munger, K., and Harlow, E. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science (Wash. DC), 243: 934-937, 1989.
40. Helt, A. M., Funk, J. O., and Galloway, D. A. Inactivation of both the retinoblastoma tumor suppressor and p21 by the human papillomavirus type 16 E7 oncoprotein is necessary to inhibit cell cycle arrest in human epithelial cells. J. Virol., 76: 10559-10568, 2002.
41. Westbrook, T. F., Nguyen, D. X., Thrash, B. R., and McCance, D. J. E7 abolishes raf-induced arrest via mislocalization of p21(Cip1), Mol. Cell. Biol., 22: 7041-7052, 2002.